Dr. Sabri Markabi joins MedinCell’s supervisory board Jacou, 6 July 2017. MedinCell announces that Sabri Markabi, M.D. who was formerly Head of Clinical Neurosciences at Novartis and Senior VP of R&D at Alcon, has been appointed to its Board of Directors. Sabri Markabi, brings with him many years of experience in the field of pharmaceutical development […]

MedinCell enters into a technology agreement for long-acting injectable products. February 4, 2016 – CORPORATE, PRESS RELEASE MedinCell and Sandoz will develop and commercialize long-acting injectable products based on BEPO™ technology with a primary focus on oncology. The alliance is part of MedinCell’s network strategy to significantly improve current standard of care, reduce total costs […]

Corbion and MedinCell form joint venture to supply resorb-able polymers for controlled drug release. August 10, 2015 Corbion and MedinCell are establishing a 50/50 joint venture for the supply of PEG (polyethylene glycol) and PLA (polylactic acid) based co-polymers in the field of controlled release drug delivery. The joint venture, CM Biomaterials, will sell the […]